Research Articles
Protocol Amendments in Clinical Trials: A Comparative Analysis of Commercial vs. Academic Challenges and Solutions
This article provides a comprehensive analysis of protocol amendments in commercial and academic clinical trials, offering critical insights for researchers, scientists, and drug development professionals.
Navigating Change: A Comparative Analysis of Amendment Processes in Clinical Research, Regulation, and Governance
This article provides a comprehensive comparison of amendment processes across clinical research, regulatory, and constitutional systems.
Protocol Amendment Rates: A Comparative Analysis of Phase I vs Phase III Clinical Trials
This article provides a comprehensive analysis of protocol amendment rates, causes, and impacts in Phase I versus Phase III clinical trials.
Protocol Amendments and Clinical Trial Timelines: Current Impacts, Costs, and Optimization Strategies
This article examines the profound impact of protocol amendments on clinical trial efficiency, drawing on recent 2024 data.
Preventing Amendment-Related Protocol Deviations: A 2025 Strategic Guide for Clinical Researchers
This article provides clinical researchers and drug development professionals with a comprehensive framework for preventing protocol deviations stemming from amendments.
Navigating EDC System Updates After Protocol Amendments: A 2025 Strategic Guide for Clinical Researchers
This article provides a comprehensive guide for clinical researchers and drug development professionals on managing electronic data capture (EDC) system updates following protocol amendments.
Navigating Patient Reconsent: A Strategic Guide for Managing Protocol Amendments in Clinical Trials
This article provides clinical researchers and drug development professionals with a comprehensive framework for managing the patient reconsent process following protocol changes.
The High Price of Change: Quantifying and Controlling Protocol Amendment Costs in Clinical Trials
Protocol amendments are a pervasive and costly reality in clinical development, with recent data indicating 76% of trials require them at a direct cost of up to $535,000 each.
Protocol Resilience: Data-Driven Strategies to Minimize Costly Clinical Trial Amendments
Clinical trial protocol amendments are a major source of delay and cost, with recent data indicating 76% of trials require them, at an average cost of over $500,000 per amendment.
Navigating IRB Amendment Applications: A Researcher's Guide to Avoiding Common Problems and Delays
This guide provides researchers, scientists, and drug development professionals with a comprehensive framework for successfully navigating the Institutional Review Board (IRB) amendment process.